Survivorship progress report

(a) In general Not later than 6 months after the date of enactment of this Act, the Secretary shall enter into an agreement with the Government Accountability Office to conduct a study of the progress made in cancer survivorship over the period beginning on the date of enactment of the National Cancer Act of 1971 (Public Law 92–216). (b) Scope of the study The study under subsection (a) shall investigate developments over the period described in subsection (a) in— (1) the nature and quality of survivorship care; (2) transitions from active treatment to survivorship care; (3) the quality of life of cancer survivors; (4) outcomes for cancer survivors; (5) disparities in access to care and survivorship outcomes; (6) the health care systems for providing survivorship care; (7) the contribution of community-based services to the survivorship care system; and (8) payment for survivorship care by public and private third-party payors. (c) Role of office of cancer survivorship The study under subsection (a) shall— (1) consider the contribution of the Office of Cancer Survivorship to the evolution of cancer survivorship care over the last 25 years; and (2) assess the impact of the mission of the Office and the resources provided to the Office on its leadership in cancer survivorship care. (d) Public meeting In conducting the study under subsection (a), the Comptroller General of the United States shall hold a public meeting with a broad cross section of stakeholders to inform the study’s findings and conclusions. Such stakeholders shall include— (1) cancer survivors and their caregivers and families; (2) patient organizations representing cancer survivors; (3) oncologists involved in survivorship care and the professional societies representing them; (4) primary care providers involved in survivor-ship care and the professional societies representing them; (5) other health professionals providing survivorship care and the professional societies representing them; (6) community-based organizations involved in survivorship care; (7) representatives of the National Cancer Institute; (8) third-party payors; (9) researchers engaged in survivorship research; (10) epidemiologists with knowledge of trends in cancer survivorship; and (11) such other stakeholders as the Comptroller General deems important to participate in the public meeting. (e) Report The Comptroller General of the United States shall— (1) release a report on the results of the study under subsection (a); and (2) in addition to the public meeting convened under subsection (d)— (A) convene another public meeting to be held on the day of the release of the report; and (B) include in such meeting all categories of stakeholders listed in subsection (d).